You are here : Home Healthcare Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market Drug formulations ATC Antiinfectives for Systemic Use Vaccines Animal Vaccines

Global Inactivated vaccines Market Research Report

Inactivated vaccines and Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

Inactivated vaccines can be segmented by Types, Geographies, MacroIndicators, Companies and Products. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia and Rest of World. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Healthcare and Other Companies. Products of this market are Livestock, Porcine, Poultry, Companion animal vaccines, Equine and Aquaculture.

Key Questions Answered

What are market estimates and forecasts; which of Inactivated vaccines markets are doing well and which are not?
What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in Inactivated vaccines?

What makes our report unique?

This report provides market sizing and forecast for the Inactivated vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.

Audience for this report

Global Inactivated vaccines companies
Manufacturing Companies
Traders, distributors, and suppliers
Governmental and research organizations
Associations and industry bodies
Technology providers

	PRODUCT TITLE	PUBLISHED
	North American Inactivated vaccines Market The North American Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $627 million in 2013 and expected to be $818 million by 2018 at a CAGR of 5.5%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	European Inactivated vaccines Market The European Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $744 million in 2013 and expected to be $1026 million by 2018 at a CAGR of 6.6%. European Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming
	Asian Inactivated vaccines Market Research Report The Asian Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $333 million in 2013 and expected to be $610 million by 2018 at a CAGR of 12.9%. Asian Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.	Upcoming

3 of 3 items

3 reports | Show

Connect With Us

US/CAN : +1-888-502-0539

sales@micromarketmonitor.com

Subscription

Animal Vaccines